ArticleThe Lancet. Haematology2019

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.

Joshua Ml Casan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.